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Ana Terriente-Félix1, Lidia Pérez1, Sarah J. Bray2, Angel R. Nebreda1,3,* and Marco Milán1,3,*
ABSTRACT
Myeloproliferative neoplasms (MPNs) of the Philadelphia-negative
class comprise polycythaemia vera, essential thrombocythaemia and
primary myelofibrosis (PMF). They are associated with aberrant
numbers of myeloid lineage cells in the blood, and in the case of overt
PMF, with development of myelofibrosis in the bone marrow and
failure to produce normal blood cells. These diseases are usually
caused by gain-of-function mutations in the kinase JAK2. Here, we
use Drosophila to investigate the consequences of activation of the
JAK2 orthologue in haematopoiesis. We have identified maturing
haemocytes in the lymph gland, the major haematopoietic organ in
the fly, as the cell population susceptible to induce hypertrophy upon
targeted overexpression of JAK. We show that JAK activates a feed-
forward loop, including the cytokine-like ligand Upd3 and its receptor,
Domeless, which are required to induce lymph gland hypertrophy.
Moreover, we present evidence that p38 MAPK signalling plays a key
role in this process by inducing expression of the ligand Upd3.
Interestingly, we also show that forced activation of the p38 MAPK
pathway in maturing haemocytes suffices to generate hypertrophic
organs and the appearance of melanotic tumours. Our results
illustrate a novel pro-tumourigenic crosstalk between the p38 MAPK
pathway and JAK signalling in a Drosophila model of MPNs. Based
on the shared molecular mechanisms underlying MPNs in flies and
humans, the interplay between Drosophila JAK and p38 signalling
pathways unravelled in this work might have translational relevance
for human MPNs.
KEY WORDS: JAK, p38 MAPK, Myeloproliferative neoplasm,
Haemocyte, Hypertrophy, Drosophila
INTRODUCTION
Myeloproliferative neoplasms (MPNs) arise in patients having a
gain-of-function mutation in Janus kinase 2 (JAK2) or the
myeloproliferative leukaemia protein receptor (MPL). Three
specific subtypes of MPN occur, polycythaemia vera, essential
thrombocythaemia or primary myelofibrosis (PMF), depending on
the blood cell typewhose concentrations are outside the homeostatic
range. Although these subtypes are less severe than some other
types of MPNs, such as chronic myelogenous leukaemia, which is
caused by the translocation BCR-Abl (Philadelphia chromosome),
15% of patients exhibit PMF and a small percentage develop acute
myeloid leukaemia, both of which compromise life expectancy. In
2005, JAK2V617F was identified as one of the most common
mutations causing the disease (Baxter et al., 2005; James et al.,
2005; Kralovics et al., 2005; Pecquet et al., 2010). Subsequently,
this mutation was shown in murine models to be sufficient to induce
activation of the JAK2 pathway in the bone marrow, and to increase
the rates of proliferation of myeloid cells (Lacout et al., 2006). Long
before the causal role of JAK2V617F in MPNs was known,
Drosophila JAK gain-of-function mutations were shown to cause
hypertrophy of the fly haematopoietic organs (lymph glands), and
enhanced proliferation of circulating blood cells (haemocytes) and
melanotic tumours (Corwin and Hanratty, 1976; Luo et al., 1997;
Minakhina and Steward, 2006; Myllymäki and Rämet, 2014;
Sorrentino et al., 2002).
In Drosophila, the conserved JAK/STAT signalling pathway is
activated when ligands Unpaired (Upd) 1, 2 or 3, four-helix bundle
cytokines of the Interleukin-6 family (Oldefest et al., 2013), bind to
homodimers of the receptor Domeless (Dome), a type I cytokine
receptor (Brown et al., 2001). This interaction promotes the
anchoring of two JAK molecules at the intracellular domain of
Dome, which allows JAK (also known as Hopscotch or Hop) trans-
phosphorylation. Activated JAK then phosphorylates the
transcription factor Stat92E, inducing its dimerization and nuclear
translocation to promote transcription (Müller et al., 2005; Rivas
et al., 2008). Functionally, JAK/Stat92E signalling is known to
positively regulate cell proliferation. It does so in different cellular
contexts under homeostatic conditions, and also, in response to
stress signals. For instance, it is particularly important at sites of
wound healing (Katsuyama et al., 2015; Santabárbara-Ruiz et al.,
2015), in cells that lose their apico-basal polarity (Bunker et al.,
2015) and in cells that experience chromosomal instability
(Clemente-Ruiz et al., 2016), as well as regulating the growth of
epithelial primordia (Mukherjee et al., 2005; Recasens-Alvarez
et al., 2017). Similarly, the JAK pathway is required in the midgut
epithelia for normal cell lineage differentiation and proliferation
(Beebe et al., 2010), a requirement that is strongly evidenced under
bacterial infection or stress assaults (Buchon et al., 2009; Cronin
et al., 2009; Jiang et al., 2009). In the lymph gland, JAK signalling
is required for the maintenance of progenitors in a naïve state (Gao
et al., 2009), whereas peripheral tissues subjected to stress respond
to the secretion of the ligand Upd3 by circulating haemocytes
(Pastor-Pareja et al., 2008; Yang et al., 2015; Agaisse et al., 2003).
Another pathway that responds to stress is the p38 mitogen-
activated protein kinase (p38 MAPK) cascade. In vertebrates, the
p38 MAPK pathway can regulate cell cycle arrest, apoptosis or
senescence, as well as the production of inflammatory mediators
(Cuadrado and Nebreda, 2010). In Drosophila, the structurally andReceived 3 October 2016; Accepted 1 February 2017
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functionally conserved p38 MAPK signalling pathway is activated
upon heat-shock (Inoue et al., 2001; Seisenbacher et al., 2011),
osmotic stress (Inoue et al., 2001; Sano et al., 2005; Seong et al.,
2011; Seisenbacher et al., 2011) and oxidative stress (Vrailas-
Mortimer et al., 2011; Santabárbara-Ruiz et al., 2015; Clemente-
Ruiz et al., 2016), and promotes survival upon exposure to
chromosomal instability (Clemente-Ruiz et al., 2016), oxidative
stress (Craig et al., 2004; Cai et al., 2011; Vrailas-Mortimer et al.,
2011) and pathogenic bacteria (Chen et al., 2010; Ha et al., 2009;
Park et al., 2009). The physiological role of the p38 MAPK
signalling pathway in the lymph gland and its potential contribution
to how these cells cope with stress conditions remain to be
elucidated.
Here, we report a Drosophila model of MPNs based on forced
expression of JAK (hop) in the lymph gland, and identify the
maturing haemocytes as the cell population susceptible to induce
JAK-induced hypertrophy. We unravel a feed-forward loop in the
JAK/STAT pathway that involves the ligand Upd3 and its receptor
Dome, and contributes to JAK-induced hypertrophy. We also show
that the p38 MAPK pathway contributes to this feed-forward loop
by regulating expression of the ligand Upd3, and, most interestingly,
when activated in maturing haemocytes, suffices to induce lymph
gland hypertrophy and melanotic tumours.
RESULTS
Targeted expression of JAK in maturing haemocytes
induces lymph gland hypertrophy
Animals bearing the JAKTum-l gain-of-function mutation, a
hyperactive form of JAK, show hypertrophic lymph glands.
This hypertrophy can also be obtained by targeted overexpression
of a wild-type form of JAK to this organ (Harrison et al., 1995).
The Drosophila larval lymph gland is composed of five to seven
pairs of posterior secondary lobes and one pair of anterior
primary lobes. Primary lobes are mainly subdivided into two
domains: the medullary zone (MZ) and the cortical zone (CZ)
(Jung et al., 2005). Naïve progenitors residing in the MZ progress
into the CZ to differentiate (reviewed in Martinez-Agosto et al.,
2007). In healthy larvae, progenitors residing in the CZ give rise
to two cell types: the crystal cells (CCs, platelet-like cells) and the
plasmatocytes (PLs, macrophage-like cells; Fig. 1A). In larvae
parasitized by wasp eggs, progenitors differentiate into a third cell
type, lamellocytes (LMs) (Jung et al., 2005). In order to identify
the cell domain that is susceptible to over-proliferation upon JAK
overexpression, a wild-type form of JAK was overexpressed in
the MZ and CZ domains by the use of the dome-Gal4 and pxn-
Gal4 drivers, respectively (Fig. 1A). The size of the resulting
lymph glands and of the JAK-overexpressing domains was
analysed in mid third-instar larvae [mid-L3; 91-94 h after egg
laying (AEL)]. When JAK was overexpressed in the pxn+
population, lymph glands were significantly larger than controls
in this developmental stage (Fig. 1B,C). By contrast, expression
of JAK in the dome+ population resulted in fewer dome+ cells
and smaller glands than controls (Fig. 1D). The overgrown glands
in pxn>JAK primarily comprised enlarged secondary lobes,
whereas primary lobes remained after apparent release of their
cell contents (Fig. 1B,C, RFP, white channel, primary and
secondary lobes). Such ‘bursting’ normally only occurs at
metamorphosis and must be greatly accelerated in the pxn>JAK
animals. In addition, the small number of pxn+ cells which are
normally present at mid-L3 in wild-type glands (Fig. S1A, wild
type, pxn>+) must become greatly expanded upon overexpression
of JAK.
In order to identify the stage at which JAK induces growth of
the pxn+ population in the primary lobes, we analysed the size of
Fig. 1. Hypertrophic lymph glands induced by JAK overexpression in the cortical zone. (A) Schematic of the primary and secondary lobes indicating the
medullary zone (MZ, dome+) and cortical zone (CZ, pxn+), and the three different cell types: crystal cells (CC, Lz+), plasmatocytes (PL) and lamellocytes
(LM, βInt-ν+). (B-F) Larval lymph glands of the indicated genotypes were labelled to visualise Hemese (He, green, B,C), RFP (red or white, B-F), DAPI (D,E),
Lozenge (Lz, green or white, E) and Atilla/L1 (L1, green or white, F). CZ (pxn-gal4) or MZ (dome-gal4) drivers were used to express RFPand/or awild-type form of
JAK in the lymph gland of mid third-instar larvae (mid-L3; 91-94 h AEL, B,C,F) or larvae at the L2-L3 transition (E). Note in C that the secondary lobes grow in JAK-
overexpressing lymph glands and the primary lobes have released their content. Inset in C shows a higher magnification of an overgrown secondary lobe
consisting of large and elongate-shaped lamellocytes. Single images of a larger area have been assembled in C to show an overgrown lymph gland induced by
JAK overexpression. Red arrows in E indicate Lz-positive cells. Red arrows in F highlight the presence of the lamellocyte marker L1. (G) mRNA levels of βInt-ν and
hemese (he) measured as the mean±s.e.m. increase in JAK-overexpressing lymph glands compared with wild-type lymph glands. Expression of the βInt-ν
lamellocyte-specific gene increases (fold change=9.1, P=0.039), whereas the expression of the haemocyte-specific gene he does not change significantly
(fold change=1.55, P=0.31). Wild-type controls were given the value of 1 and are not displayed in the figure. *P<0.05. Scale bars: 40 µm (B-E), 20 µm (F).
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JAK-overexpressing lymph glands at early stages of larval
development. We focused particularly on the transition between
second- to third-instar larvae (L2-L3 transition; 69-72 h AEL) as
this stage was previously shown to be critical for the generation of
melanotic tumours in a JAKTum-l background (Hanratty and
Dearolf, 1993). We found that the pxn-Gal4 driver started to be
expressed in wild-type lymph glands 6 h prior to the L2-L3
transition (Fig. S1B, wild type, pxn>+). Interestingly, JAK-
overexpressing glands showed a faster growth rate than controls
across all time points analysed, which resulted in larger glands
with a larger population of pxn+ cells (Fig. S1C, pxn>JAK).
Furthermore, these primary lobes did not, at this stage, show signs
of having burst and released their cell content to the haemolymph.
Since each primary lobe could be analysed individually, we
selected the developmental stage at the L2-L3 transition for further
characterisation of the lymph gland hypertrophy caused by JAK
overexpression (see below).
To investigate the similarities between the JAKTum-l mutant and
JAK overexpression, we analysed the cell differentiation state.
Larvae mutant for JAKTum-l showed melanotic tumours, which
consist of aggregates of lamellocytes (Minakhina and Steward,
2006), and a reduced number of crystal cells in circulation (Hanratty
and Dearolf, 1993; Harrison et al., 1995). When JAK was
overexpressed in the pxn+ cell population, crystal cells, visualised
by the expression of Lozenge (Lz+; Jung et al., 2005), rarely
differentiated (Fig. 1E, red arrows). In these lymph glands, a
multitude of large, elongated lamellocytes were detected (Fig. 1C,
inset). These cells were also identified by expression of the specific
lamellocyte marker Atilla/L1 (Kurucz et al., 2007) (Fig. 1F).
Accordingly, in the pxn>JAK glands, we detected a significant
increase in the expression levels of the lamellocyte-specific gene β-
integrin-ν (βInt-ν; Kwon et al., 2008) compared with the pan-
haemocyte marker hemese (he) (Jung et al., 2005) (Fig. 1G). Taken
together, these results indicate firstly that pxn+ cells are the most
susceptible cell population to outgrow upon JAK overexpression,
and secondly, that JAK induces a cell fate shift towards lamellocyte
differentiation, at the expense of the crystal cells. Whether the
increased number of lamellocytes observed in JAK-overexpressing
lymph glands arises through the active proliferation of a normally
quiescent lamelloblast population (Anderl et al., 2016) or through a
programme of divisions and cell fate respecification amongst the
plasmatocytes, remains to be elucidated.
An Upd3-mediated feed-forward loop contributes to JAK-
induced lymph gland hypertrophy
To analyse the physiological role of JAK/STAT in the pxn+ cell
population, we knocked down JAK expression using JAKRNAi and
quantified the percentage of pxn+ cells in each lymph gland at mid-
L3. The resulting primary lobes displayed no significant changes in
the proportion of cells in the pxn+ population when compared with
wild-type controls (Fig. S2A). Similarly, when we expressed a
truncated form of the receptor Dome, which lacks the intracellular
domain (DomeΔCYT; Brown et al., 2001), we did not observe any
changes in the percentage of pxn+ cells per gland (Fig. S2A,
pxn>domeΔCYT). As control, we knocked down JAK in the dome+ cell
population, and observed at mid-L3 a reduced number of dome+ cells
in the MZ (Fig. S2B, MZ), which gave rise to smaller lymph glands
(Fig. S2B, Total). This is consistent with the proposed role of JAK
signalling in regulating the proliferation and/or survival of the cells
residing in theMZ (Makki et al., 2010). Thus, our results indicate that
the JAK/Dome pathway is either not required or has a redundant role
with other signalling pathways during normal CZ development.
The function of the endogenous STAT (Stat92E) in the CZ was
investigated by examining at mid-L3 the effect of expressing
stat92ERNAi in the pxn+ cell population. As previously reported
(Minakhina et al., 2011; Mondal et al., 2011), lymph glands with
stat92E knockdown resembled, although to a milder extent, the
phenotype resulting from upregulation of JAK. This is shown by the
expansion of the pxn+ cell population (Fig. 2A). Previous work in
Drosophila has identified a non-canonical mechanism by which the
unphosphorylated form of Stat92E maintains HP1a localisation and
heterochromatin stability (Shi et al., 2008). We thus wondered
whether the ability of JAK to induce hypertrophy of the pxn+ cell
population relied, at least in part, on the release of Stat92E from the
heterochromatin. To avoid JAK-overexpressing glands bursting,
primary lobes were examined at the L2-L3 transition. At this
developmental time, the effect of knocking down Stat92E in pxn-
expressing cells was milder (Fig. 2B, compare pxn>stat92ERNAi
with pxn>+). However, we observed that the co-expression of
stat92ERNAi together with JAK did not enhance the JAK-induced
hypertrophy (Fig. 2B). By contrast, and consistent with a canonical
role of Stat92E in mediating JAK activity, the downregulation of
Stat92E resulted in a significant rescue of the JAK-induced
expansion of the pxn+ cell population (Fig. 2B, compare
pxn>JAK+stat92ERNAi with pxn>JAK). These results indicate that
Stat92E is required downstream of JAK to sustain the growth of the
CZ, independent of its non-canonical role in the repression of the
CZ expansion in wild-type conditions.
We next studied the requirement for the receptor Dome in JAK-
induced hypertrophy. We observed that co-expression of the
truncated receptor DomeΔCYT greatly reduced the expansion of
the pxn+ cell population caused by JAK overexpression (Fig. 2C).
Since the receptor Dome was apparently required for JAK-induced
lymph gland hyperplasia, we investigated whether its ligands were
also involved. Consistent with the requirement for Dome, JAK
overexpression in larvae homozygous for a deficiency depleting the
coding sequences of upd2 and upd3 resulted in a considerable
reduction of the pxn+ cell population compared with JAK
overexpression alone (Fig. 2D). This suggests that JAK requires
both the receptor and its ligands to induce lymph gland overgrowth.
Then, we directly analysed the expression of the ligands in
hypertrophic glands by RT-qPCR and found that upd3 was
strongly upregulated upon JAK overexpression, whereas upd2
was increased to a lesser extent (Fig. 2E). Consistent with this result,
we found that an upd3 enhancer, previously shown to be activated in
Drosophila neoplastic tumours (Bunker et al., 2015), was expressed
in scattered pxn+ cells overexpressing JAK but not in the wild-type
glands (Fig. 2F). Using an upd3-RNAi form, we confirmed that the
overproliferation of JAK-overexpressing pxn+ cells requires Upd3
(Fig. 2C). Taken together, we conclude that JAK induces a feed-
forward loop that triggers upd3 expression, which contributes to
JAK-induced hypertrophy of the lymph gland.
A role for p38 MAPK signalling in maturing haemocytes
The p38 MAPK signalling pathway is an important regulator of
cytokine and chemokine expression in mammals (reviewed by
Clark and Dean, 2012; Cuadrado and Nebreda, 2010). We thus
investigated the possible interplay between the p38MAPK and JAK
pathways in lymph gland hypertrophy. We first analysed the effect
of expressing in the lymph gland a wild-type form of Licorne (Lic),
the Drosophila protein kinase that activates p38a and p38b MAPKs
(Adachi-Yamada et al., 1999; Han et al., 1998; Inoue et al., 2001),
or an activated form (Licact, see Materials and Methods for details).
Interestingly, when Lic was overexpressed in the cortical zone with
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the pxn-Gal4 driver, large melanotic aggregates were observed
under the cuticle (Fig. 3A). The proportion of larvae bearing large
melanotic aggregates was even higher upon overexpression of Licact
in the pxn+ cell population (Fig. 3A). Whereas lymph glands
overexpressing Lic showed larger primary lobes than controls
(Fig. 3B,E, compare pxn>+ with pxn>lic), the overgrowth observed
in pxn>licact glands was due to the increase in size of secondary
lobes as primary lobes showed signs of having released their cell
content (Fig. 3D). At earlier stages of development, the primary
lobes of pxn>licact glands showed a similar growth pattern to the
JAK-overexpressing glands (Fig. S1D). Moreover, Licact-expressing
glands showed numerous lamellocytes, as detected microscopically
by their large size and elongated shape (Fig. 3D, left inset), by the
expression of the lamellocyte marker Attila/L1 (Fig. 3F, red arrows,
green and white channel) and by the elevated mRNA expression
levels of the lamellocyte-specific marker βInt-ν (when compared
with the pan-haemocyte marker he; Fig. 3G). In addition, lymph
glands contained a reduced number of crystal cells labelled by the
expression of Lozenge (Fig. 3H, red arrows, compare with Fig. 1E).
Overexpression of Lic in the MZ produced primary lobes of about
the same size as in the wild-type glands (Fig. 3C), whereas
expression of Licact in the MZ caused larval lethality, most probably
due to the expression of the dome-Gal4 driver in the embryo.
Altogether, these results indicate that activation of the Licorne/p38
MAPK signalling pathway in the pxn+ cell population phenocopies
the effects of JAK overexpression and induces lymph gland
dysplasia.
To analyse whether the p38 MAPK pathway has a role in the
lymph gland during normal development, we studied hemizygous
licnull mutants. As previously described (Cully et al., 2010), larvae
with reduced levels of Lic activity were smaller than wild-type larvae
(data not shown). Consistently, their lymph glands were also smaller
than lymph glands from wild-type larvae of the same developmental
age (Fig. 4A). We next analysed the role of endogenous p38 MAPK
signalling in the different regions of the lymph gland. For this
purpose, we used RNAis targeting p38a and p38b, lic or the
downstream transcription factor dATF-2 (Han et al., 1998; Sano et al.
2005). Targeted expression of these RNAis to the CZ resulted in a
Fig. 2. JAK-induced hypertrophy requires Stat92E, Dome and Upd3. (A-C) Scatterplots and immunofluorescence images showing the proportion of pxn+
cells per primary lobe (% pxn+/N cells) and lymph glands expressing the indicated transgenes under the control of the pxn-Gal4 driver. Lymph glands were
extracted from mid-L3 larvae (A) or larvae aged at the L2-L3 transition (B,C) and labelled to visualise RFP (red), and DAPI (blue). (A) Expansion of the
stat92ERNAi-expressing cell population compared with the control pxn>+ cell population (P=0.0087; pxn>+, n=21; pxn>stat92ERNAi, n=14). (B) Knockdown of
stat92E partially rescues the JAK-induced expansion of the pxn+ population (P=0.0004; pxn>JAK, n=33; pxn>JAK+stat92ERNAi, n=23) whereas stat92ERNAi
produces a subtle increase in the proportion of pxn+ cells compared with the control pxn>+ cell population (P=0.03; pxn>+, n=25; pxn>stat92ERNAi, n=21).
(C) Knockdown of upd3 or expression of DomeΔCYT reduces the JAK-induced expansion of the pxn+ population (pxn>JAK+domeΔCYT: P=1.961e−10, n=22;
pxn>JAK+upd3RNAi: P=0.00234, n=20; pxn>JAK, n=44). (D) Lymph glands expressing JAK under the control of the pxn-Gal4 driver were extracted and labelled
as in B,C. Note the reduction in the expansion of the pxn+ cell population in upd2Δ, upd3Δmutant lymph glands. (E) Increases in mRNA levels of upd3 and upd2 in
lymph glands expressing JAK under the control of the pxn-gal4 driver when compared with controls, which were given the value of 1. Note a significant increase
in the expression level of upd3 (fold-change=72.45,P=0.00013) but not in the expression level of upd2 (fold-change=8.32,P=0.15). (F) Lymph glands expressing
the indicated transgenes under the control of the pxn-Gal4 driver were extracted from larvae aged at the L2-L3 transition and labelled to visualise upd3-lacZ
expression (antibody against βGal, green or white), RFP (red), and DAPI (blue). Note induction of upd3-lacZ expression in JAK-overexpressing lymph glands.
*P<0.05; **P<0.01; ***P<0.001. Every dot represents a single primary lobe. Red horizontal bar represents the mean, and whiskers represent 5% and 95%
percentiles. The contour of the lymph glands is marked in B,D and F. Scale bars: 40 µm (A-D,F).
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reduced number of pxn+ cells compared with wild-type glands at
mid-L3 (Fig. S3A). By contrast, targeted depletion of lic in the MZ
did not reduce the number of dome+ progenitors and the lymph
glands showed a subtle enlargement (Fig. S3B, Total). Consistent
with a specific requirement of the Licorne/p38 MAPK signalling
pathway in the CZ, expression of Licact under control of the pxn-Gal4
driver produced lymph glands of similar size in both licnull mutant
and wild-type control animals raised in parallel and visualised at the
transition between L2 and L3 (Fig. 4B). Taken together, these results
indicate that the p38 MAPK pathway has a role in regulating growth
of the pxn+ cell population during normal development.
A role for p38MAPK signalling in JAK-induced hypertrophyof
the lymph gland
The above experiments indicate that activation of p38 MAPK
signalling in the CZ phenocopies the JAK-induced lymph gland
hypertrophy and the cell fate shift towards lamellocyte
differentiation. In order to test whether p38 MAPK signalling
contributes to the JAK-induced phenotype, we analysed the ability
of JAK overexpression to induce hypertrophic lymph glands in a
licnull mutant background. Interestingly, lic-deficient lymph glands
showed a reduced expansion of the pxn+ cell population and a
smaller size upon overexpression of JAKwhen compared with wild-
type glands (Fig. 4C, compare pxn>JAK with licnull; pxn>JAK).
Consistent with this result, co-expression of the kinase-dead form of
p38b ( p38bKD; which can act as a dominant-negative form blocking
p38 MAPK signalling) with RNAi specific for MK2 [MK2RNAi; a
protein kinase activated by p38 MAPK (Cuadrado and Nebreda,
2010)] or the transcription factor dATF-2 (dATF-2RNAi), were able
to rescue the expansion of the pxn+ cell population caused by JAK
overexpression (Fig. 4D). These data confirm that p38 MAPK
signalling is required downstream of the JAK/STAT pathway to
promote the expansion of the pxn+ cell population. We also
observed that JAK overexpression induced high levels of apoptosis,
as monitored by an antibody that detects the cleaved form of the
effector caspase Dcp1, which was rescued by dATF-2 depletion
(Fig. 4E). Whether the induction of cell death is a direct
consequence of p38 MAPK activation or an indirect consequence
of the enhanced proliferative capacity of the tissue upon JAK
overexpression remains to be elucidated.
Fig. 3. Hypertrophic lymph glands induced by expression of an activated form of Licorne in the cortical zone. (A) Histogram showing the percentage of
larvae bearing small (puncta) or big (aggregates) melanotic tumours upon expression of wild-type (lic, green) or an activated form (licact, yellow) of Licorne under
the control of the pxn-gal4 driver. Representative examples of a wild-type larva and of a larva bearing a big melanotic tumour are shown. Lic, n=93 larvae; licact,
n=109 larvae. (B,D,E) Lymph glands expressing the indicated transgenes under the control of the pxn-Gal4 driver were extracted frommid third-instar larvae (mid-
L3) and labelled to visualise RFP (red or white) and Hemese (He, green). Note that the secondary lobes grow in Licact-expressing lymph glands (D), but their
associated primary lobes have released their content. Inset in D shows a higher magnification of large, elongated lamellocytes. Also note that the primary lobes in
Lic-overexpressing lymph glands (E) are larger than wild-type controls (B). (C) Lymph glands overexpressing Lic under the control of the dome-Gal4 driver
extracted from mid third-instar larvae (mid-L3) and labelled to visualise RFP (red) and DAPI (blue). (F) Expression of Licact in pxn+ cells induces differentiation of
lamellocytes in mid-L3. Lamellocytes are distinguished by the expression of L1/Atilla (L1, green or white) and their large and elongated shape outlined by
Phalloidin (Phal, blue); RFP visualises pxn+ cells (red). Note an increase of L1+ cells (red arrows). (G) IncreasedmRNA levels of βInt-ν and hemese (he) in lymph
glands expressing Licact when compared with controls (fold-change increase of βInt-ν=76.50, P=0.03; fold-change of he=3.38, P=0.0052). Controls were given
the value of 1 and are not displayed in the figure. **P<0.01. (H) Lymph gland expressing Licact under the control of the pxn-Gal4 driver extracted from a larva at the
L2-L3 transition and labelled to visualise RFP (red), Lozenge (Lz, green or white) and DAPI (blue). Note a reduced number of Lozenge-expressing cells (red
arrows). The contour of the lymph gland is marked in H. Single images of a larger area have been assembled in D and E to show overgrown lymph glands induced
by overexpression of Licact or Lic, respectively. Scale bars: 40 µm (B-E,H), 20 µm (F).
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Next, we analysed whether p38 MAPK signalling is required
downstream of the JAK pathway to regulate upd3 expression. We
found that lymph glands co-expressing JAK together with p38bKD
showed lower expression levels of upd3 than lymph glands
overexpressing JAK alone (Fig. 4F). In addition, expression of
constitutively active Licact sufficed to upregulate upd3 expression in
lymph glands (Fig. 4F), and upd3 was upregulated by Licact to a
greater extent than ligands such as Spatzle or Eiger (Fig. S4A), which
can activate the Toll and JNK pathways, respectively, and induce
melanotic tumours (Qiu et al., 1998; Zettervall et al., 2004). We
confirmed in Kc167 cells that expression of Licact sufficed to induce
upregulation of upd2 and upd3 (Fig. S4B), and this required p38
MAPK activation because levels were reduced when Licact was
expressed in the presence of the p38 MAPK inhibitor SB203580
(Fig. S4B). In order to test whether the increased expression of upd2
and upd3 resulted in activation of the JAK/STAT pathway, we
analysed the activity of 6x2xDrafLuc, a reporter widely used to
measure the activity of this pathway (Thomas et al., 2015; Müller
et al., 2005). Luciferase assays revealed increased reporter activity in
Kc167 cells expressing Licact or JAKTum-l, and to a lesser extent upon
overexpression of wild-type JAK (Fig. S4C). Altogether, these results
support the implication of the p38MAPK signalling pathway in JAK-
induced lymph gland hypertrophy by regulating upd3 expression.
DISCUSSION
Here, we have analysed the impact of JAK overexpression in the
different cell populations of the lymph gland, the major
haematopoietic organ of Drosophila. This has allowed us to
identify the maturing haemocytes as the cell population that is
responsible for JAK-induced hypertrophy. In addition, JAK-
overexpressing lymph glands showed increased numbers of
differentiated lamellocytes and fewer crystal cells, a phenotype
that resembles the effect of JAKTum-l mutants. Using this model, we
have identified a number of essential components in the JAK/STAT
pathway that have an important role in JAK-induced lymph gland
dysplasia. First, the transcription factor Stat92E was found to be a
necessary element downstream of JAK, independent of its role in
preventing expansion of the cortical zone in wild-type conditions.
This result concurs with previous publications showing that
phosphorylation of Stat92E in JAKTum-l haemocytes is required
for the formation of melanotic tumours (Bausek and Zeidler, 2014;
Remillieux-Leschelle et al., 2002; Sorrentino et al., 2004). We
speculate that Stat92E regulates a set of genes in wild-type
conditions that prevent the expansion of the pxn+ population, and
that these genes are different from those regulated upon JAK
phosphorylation, which might be involved in dysplastic growth.
This is consistent with a report showing that the unphosphorylated
and phosphorylated forms of Stat5, the vertebrate orthologue of
Stat92E, can regulate different sets of genes (Park et al., 2015). Most
interestingly, we unravelled a requirement for the Dome receptor in
JAK-induced hypertrophy, and identified the ligand Upd3 as an
essential component involved in a feed-forward loop downstream of
JAK signalling that contributes to lymph gland dysplasia. This work
complements the use of phenotypic screenings based on the
Fig. 4. A role for p38 MAPK signalling in JAK-induced hypertrophy. (A) Expression of pxn-Gal4 marked by the expression of RFP (red) in wild-type and
in licnull hemizygous lymph glands (outlined). (B,C) Expression of Licact (B) or JAK (C) under the control of the pxn-Gal4 driver in control and in licnull hemizygous
lymph glands. Scatterplot in C shows the proportion of pxn+ cells per primary lobe (% pxn+/N cells), and the total cell number per primary lobe (N cells). Note that
loss of lic induced a reduction in the number of pxn+ cells per primary lobe caused by JAK overexpression (P=0.006) and a reduction in the number of cells per
lymph gland (P=0.034; pxn>JAK, n=9; pxn>JAK+licnull, n=9). (D) Genetic interactions between p38b, dATF-2 and MK2 and JAK in the pxn+ cells. Scatterplots
show the proportion of pxn+ cells per primary lobe (% pxn+/N cells) and immunofluorescence images show lymph glands expressing the indicated transgenes
under the control of the pxn-Gal4 driver. Note that expression of p38bKD, MK2RNAi or dATF-2RNAi reduced the number of pxn+ cells per primary lobe caused by
JAK overexpression (pxn>JAK vs pxn>JAK+p38bKD, P=6.318e−06; pxn>JAK vs pxn>JAK+dATF-2RNAi, P=1.02e−06; pxn>JAK vs pxn>JAK+MK2RNAi,
P=3.848e−06; pxn>JAK, left plot, n=27 and right plot, n=14; pxn>JAK+p38bKD, n=29; pxn>JAK+dATF-2RNAi, n=10; pxn>JAK+MK2RNAi, n=23). (E) Expression of
the cleaved form of the effector caspase Dcp1 (clv-Dcp1, marked in green and white) increases upon JAK overexpression in pxn+ cells (pxn>JAK vs pxn>+,
P=0.038; pxn>+, n=8; pxn>JAK, n=13) and was rescued by the expression of dATF-2RNAi (pxn>JAK vs pxn>JAK+dATF-2RNAi, P=0.001; pxn>JAK+dATF-2RNAi,
n=12), although not to the levels observed in the wild type (pxn>JAK+d-ATF2RNAi vs pxn>+, P=0.035). (F) Increased mRNA levels of upd3 in lymph glands
expressing Licact (fold-change=71.1, P=0.0006), JAK (fold-change=158.43, P=0.0099) or JAK and p38bKD (fold-change=54.79, P=0.063) under the control of
the pxn-Gal4 driver when compared with controls (pxn>+), which were given the value of 1. In A-E, lymph glands of the different genotypes were extracted from
larvae at the L2-L3 transition and labelled to visualise RFP (red or white) and DAPI (blue). *P<0.05; **P<0.01; ***P<0.001. In the scatterplots, every dot represents
a single primary lobe; red horizontal bars represent the mean, and whiskers represent 5% and 95% percentiles. Scale bars: 40 µm.
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presence of melanotic tumours (Shi et al., 2008) and forward RNAi
screenings (Müller et al., 2005) – genetic approaches that in the past
served to identify new elements of the JAK regulatory network in
haemocytes. Furthermore, our experimental setup could be useful to
perform small-scale drug screenings or to validate hits previously
identified in drug screenings performed inDrosophila cultured cells
(Thomas et al., 2015). Of particular interest would be drugs that
synergise with JAK inhibitors, since Ruxolitinib, an FDA-approved
JAK inhibitor, does not ameliorate MPN symptoms in the long term
(Mascarenhas et al., 2014).
Our genetic model of MPNs has also allowed us to identify a
novel role for the p38 MAPK pathway in the feed-forward loop
downstream of JAK signalling that contributes to lymph gland
dysplasia. The p38 MAPK pathway exerts is function by regulating
upd3 expression. Importantly, we found that overexpression of
Licorne, a direct and specific activator of p38 MAPKs, suffices to
induce dysplasia and phenocopies the effect of JAK overexpression.
Furthermore, p38 MAPK signalling was able to induce upd3
expression in lymph gland cells and in Kc167 cells. Our data show
that the p38 MAPK pathway, including the transcription factor
dATF-2, is necessary for the maturing haemocytes to proliferate
both in wild-type conditions and in response to JAK overexpression.
Similarly, there is evidence that p38MAPK signalling can stimulate
mammalian cell proliferation in particular contexts, for example, in
mouse colon tumour cells (Gupta et al., 2014). Megakaryocyte
proliferation induced by FLT3 receptor activation has also been
reported to involve p38 MAPK signalling (Desterke et al., 2011). In
addition, the p38 MAPK pathway plays an important role in the
regulation of cytokine expression both at transcriptional and post-
transcriptional levels (reviewed by Cuadrado and Nebreda, 2010;
Tiedje et al., 2014). However, we are not aware of any report
showing that direct activation of the p38 MAPK pathway by an
upstream regulator such as Lic suffices to induce dysplasia and
tumour formation in vivo. On the contrary, p38 MAPK
hyperactivation usually leads to cell cycle arrest and cell death in
mammalian cells (Cuadrado and Nebreda, 2010; Tiedje et al., 2014).
This suggests that haemocytes, and perhaps the concurrent activation
of JAK signalling, may provide a particular context that favours a
pro-tumourigenic role for p38 MAPK signalling. Intriguingly, there
are no reports on mutations, changes in copy number, promoter
methylation or enhanced phosphorylation levels of p38 MAPKs in
samples from MPN patients (Desterke et al., 2011; Shahjahan et al.,
2008), supporting our conclusion that p38 MAPK signalling
contributes to tumourigenesis as part of the JAK-triggered feed-
forward loop. Given thatMPNpatients are known to have high levels
of circulating cytokines (Levine et al., 2007; Tyner et al., 2010), it is
tempting to speculate that p38 MAPK signalling contributes to
JAK2V617F-associated mammalian tumourigenesis by regulating the
production of cytokines, which act in an autocrine manner.
MATERIALS AND METHODS
Fly strains
The alleles and fly stocks, as described in FlyBase (flybase.org/), were pxn-
Gal4 (Stramer et al., 2005), dome-Gal4 [#PG125 (Makki et al., 2010)],
UAS-cd8RFP (BDSC #32219 and #32218), UAS-cd8GFP (BDSC #5030),
upd3-lacZ (Bunker et al., 2015), UAS-JAKHA (FlyORF #F001803),UAS-lic
(FlyORF #F001674), UAS-stat92ERNAi (VDRC #106980), UAS-upd3RNAi
(VDRC #27134), UAS-domeΔCYT (Brown et al., 2001), UAS-p38bKD
(Vrailas-Mortimer et al., 2011), w*,upd2Δ,upd3Δ (BDSC #55729), licD13
[licnull in the text (Cully et al., 2010)],UAS-JAKRNAi (BDSC #32966),UAS-
p38aRNAi (VDRC #52277), UAS-p38bRNAi (VDRC #108099), UAS-licRNAi
(VDRC #106822), UAS-dATF-2RNAi (DGGR #3749-R2 and BDSC
#60124) and UAS-MK2RNAi (VDRC #3170).
*UAS-licRNAi and UAS-stat92ERNAi were VDRC lines of the KK
collection. Because of the presence of a landing site in the gene tiptop,
lines were meiotically recombined to acquire the dominant mutation Sco.
Then, flies were PCR screened for the absence of tiptop landing site and the
presence of the correct non-annotated landing site at cytological position
40D. Then the Sco mutation was removed by meiotically recombining the
arm with a wild-type chromosome. Full genotypes of flies used for results
displayed in all figures are listed in supplementary Materials and Methods.
Generation of the UAS-licact construct
A lic ORF frame (SD04985; 321-1325 bp) was used to make a phospho-
mimetic version, by swapping serine (S200) and threonine (T204) residues
to aspartate (D). The mutated licwas cloned into pUAS to transform yw flies
(Brand and Perrimon, 1993).
Generation of cell lines
Stable lines of Kc167 cells were prepared and treated as described in
supplementary Materials and Methods.
RT-qPCR
Real-time quantitative PCR was carried out on total RNA from lymph
glands using primers listed in supplementary Materials and Methods.
Experimental setup
For Figs 1-4, Figs S2 and S3, lymph glands were extracted from larvae that
were either 69-72 h AEL (L2-L3 transition) or at 91-94 h AEL (mid-L3). To
age the larvae, eggs were collected every 3 h at 25°C and shifted to 29°C at
45-48 h AEL. In this manner, incubating lymph glands at 29°C for 24 h or
48 h, we increased the efficiency of the Gal4/UAS system. For Fig. S1B-D,
eggs were collected every 3 h. Larvae were cultured at 25°C until 63-66 h
AEL (6 h before the L2-L3 transition). Then they were shifted to 29°C and
lymph glands were dissected 6 h before the L2-L3 transition, at the L2-L3
transition and 6 h later.
Antibodies and dyes
Antibodies used were: anti-He [1:30, mouse; Istvan Ando, Institute of
Genetics Hungarian Academy of Sciences, Hungary (Kurucz et al., 2003)];
anti-Atilla/L1a,b,c [1:10, mouse; Istvan Ando (Kurucz et al., 2007)]; anti-Lz
(1:100, mouse, concentrated; DSHB); anti-βGal (1:1000, mouse; DSHB,
40.1a); anti-GFP (1:300, goat; Abcam, ab6673); anti-cleaved-Dcp1 (clv-
Dcp1; 1:100, rabbit; Cell Signaling Technology, 9578); Alexa Fluor 488
Phalloidin (1:50; Cell Signaling Technology, 8878). Secondary antibodies
for IF were from Life Technologies and Jackson Immunoresearch.
Immunofluorescence and imaging
Ten lymph gland pairs were settled on poly-L-lysine-coated slides with a
silicon well containing PBS. Samples were fixed for 20 min with 4%
paraformaldehyde at room temperature (RT), rinsed three times with 1×PBS,
5 min with 1×PBS+1% Triton X-100 (PBST) and then incubated for 1 h
with PBST plus 4% horse serum at RT. Next, samples were incubated
overnight at 4°C with primary antibodies. The following day, samples were
rinsed and washed three times for 15 min with PBST, incubated for 1 h and
15 min with secondary antibodies, washed three times for 15 min with PBST
and once with 1×PBS. To finish the mounting, the silicon well was removed
and glycerol-based medium containing DAPI (2 mg/ml) was added.
Confocal images were taken using a confocal Leica TCS SP5 microscope.
For bright-field images, live larvae were held in a drop of iced water and
photographed under an Olympus MVX10 microscope.
Cell imaging and processing
Cell imaging and processing were performed using Fiji 2.0.0, MATLAB
R2016a and Adobe Photoshop CC 2015. The brightness of all figure panels
was adjusted to normalize RFP expression levels, which labels the
transgene-expressing population and can vary from sample to sample.
Cell quantification in primary lobes
To quantify the total number of cells per primary lobe (N cells), individual
cells were considered as nuclei detected by the maximal local intensity in the
405
RESEARCH ARTICLE Disease Models & Mechanisms (2017) 10, 399-407 doi:10.1242/dmm.028118
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
DAPI channel. The nuclei were detected in two to three confocal planes.
Original data were filtered using a Laplacian filter. To measure the
proportion of cells that expressed pxn>mRFP in a single primary lobe
(% pxn+/N cells), we detected the channel RFP in shells whose centre was
the maximal detecting point of the DAPI. This shell was designed to have an
empty gap of the nuclei diameter in order to capture the intensity values
showed by cytoplasmic mRFP. Defining a threshold, we could discriminate
as positive pxn+ cells those having 75% of the maximal local intensity.
Measurements of pxn+/N cells described in the paper are linked to the ‘N
cells’ measurement presented in Fig. S5.
Statistical analyses
Between 10 and 35 samples (primary lobes) were used for each of the
quantifications. Control and experimental samples were collected and
analysed in parallel. We did not use any method for randomisation, blinding,
exclusion of any sample or to measure the variances. P-values were
calculated using Kolmogorov-Smirnov for nonparametric data. Analyses
were done with Prism 7.0 (GraphPad) and R.
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of Drosophila Stat DNA binding shows an evolutionary basis for Stat transcription
factor preferences. EMBO Rep. 9, 1114-1120.
Sano, Y., Akimaru, H., Okamura, T., Nagao, T., Okada, M. and Ishii, S. (2005).
Drosophila activating transcription factor-2 is involved in stress response via
activation by p38, but not c-Jun NH2-terminal kinase. Mol. Biol. Cell 16,
2934-2946.
Santabárbara-Ruiz, P., López-Santillán, M., Martıńez-Rodrıǵuez, I., Binagui-
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